Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

IMPAX LABORATORIES INC (IPXL) > Segments

Global Pharmaceuticals Division

Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues       448.7491.7864.7
            Revenue growth       -8.8%-43.1%150.7%
Gross profit          
            Gross margin          
Selling, general and administrative       15.411.314.6
Research and development       48.646.244.3
EBIT       145.6184.0471.2
            EBIT margin       32.4%37.4%54.5%
Pre-tax income       145.6184.0471.2
            Pre-tax margin       32.4%37.4%54.5%
   
Revenue Mix       77.1%95.9%98.3%
EBIT Mix       175.4%184.7%119.8%

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy